List of Tables
Table 1. Antibody Drug Conjugate (ADC) Drug Market Trends
Table 2. Antibody Drug Conjugate (ADC) Drug Market Drivers & Opportunity
Table 3. Antibody Drug Conjugate (ADC) Drug Market Challenges
Table 4. Antibody Drug Conjugate (ADC) Drug Market Restraints
Table 5. Global Antibody Drug Conjugate (ADC) Drug Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Antibody Drug Conjugate (ADC) Drug Revenue Market Share by Company (2019-2024)
Table 7. Key Companies Antibody Drug Conjugate (ADC) Drug Manufacturing Base Distribution and Headquarters
Table 8. Key Companies Antibody Drug Conjugate (ADC) Drug Product Type
Table 9. Key Companies Time to Begin Mass Production of Antibody Drug Conjugate (ADC) Drug
Table 10. Global Antibody Drug Conjugate (ADC) Drug Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antibody Drug Conjugate (ADC) Drug as of 2023)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global Antibody Drug Conjugate (ADC) Drug Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 14. Global Antibody Drug Conjugate (ADC) Drug Sales Value by Type (2019-2024) & (US$ Million)
Table 15. Global Antibody Drug Conjugate (ADC) Drug Sales Value by Type (2025-2030) & (US$ Million)
Table 16. Global Antibody Drug Conjugate (ADC) Drug Sales Market Share in Value by Type (2019-2024) & (%)
Table 17. Global Antibody Drug Conjugate (ADC) Drug Sales Market Share in Value by Type (2025-2030) & (%)
Table 18. Global Antibody Drug Conjugate (ADC) Drug Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 19. Global Antibody Drug Conjugate (ADC) Drug Sales Value by Application (2019-2024) & (US$ Million)
Table 20. Global Antibody Drug Conjugate (ADC) Drug Sales Value by Application (2025-2030) & (US$ Million)
Table 21. Global Antibody Drug Conjugate (ADC) Drug Sales Market Share in Value by Application (2019-2024) & (%)
Table 22. Global Antibody Drug Conjugate (ADC) Drug Sales Market Share in Value by Application (2025-2030) & (%)
Table 23. Global Antibody Drug Conjugate (ADC) Drug Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 24. Global Antibody Drug Conjugate (ADC) Drug Sales Value by Region (2019-2024) & (US$ Million)
Table 25. Global Antibody Drug Conjugate (ADC) Drug Sales Value by Region (2025-2030) & (US$ Million)
Table 26. Global Antibody Drug Conjugate (ADC) Drug Sales Value by Region (2019-2024) & (%)
Table 27. Global Antibody Drug Conjugate (ADC) Drug Sales Value by Region (2025-2030) & (%)
Table 28. Key Countries/Regions Antibody Drug Conjugate (ADC) Drug Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 29. Key Countries/Regions Antibody Drug Conjugate (ADC) Drug Sales Value, (2019-2024) & (US$ Million)
Table 30. Key Countries/Regions Antibody Drug Conjugate (ADC) Drug Sales Value, (2025-2030) & (US$ Million)
Table 31. Oxford Bio Therapeutics Basic Information List
Table 32. Oxford Bio Therapeutics Description and Business Overview
Table 33. Oxford Bio Therapeutics Antibody Drug Conjugate (ADC) Drug Products, Services and Solutions
Table 34. Revenue (US$ Million) in Antibody Drug Conjugate (ADC) Drug Business of Oxford Bio Therapeutics (2019-2024)
Table 35. Oxford Bio Therapeutics Recent Developments
Table 36. Synthon Basic Information List
Table 37. Synthon Description and Business Overview
Table 38. Synthon Antibody Drug Conjugate (ADC) Drug Products, Services and Solutions
Table 39. Revenue (US$ Million) in Antibody Drug Conjugate (ADC) Drug Business of Synthon (2019-2024)
Table 40. Synthon Recent Developments
Table 41. Progenics Pharmaceuticals Basic Information List
Table 42. Progenics Pharmaceuticals Description and Business Overview
Table 43. Progenics Pharmaceuticals Antibody Drug Conjugate (ADC) Drug Products, Services and Solutions
Table 44. Revenue (US$ Million) in Antibody Drug Conjugate (ADC) Drug Business of Progenics Pharmaceuticals (2019-2024)
Table 45. Progenics Pharmaceuticals Recent Developments
Table 46. Bayer HealthCare Basic Information List
Table 47. Bayer HealthCare Description and Business Overview
Table 48. Bayer HealthCare Antibody Drug Conjugate (ADC) Drug Products, Services and Solutions
Table 49. Revenue (US$ Million) in Antibody Drug Conjugate (ADC) Drug Business of Bayer HealthCare (2019-2024)
Table 50. Bayer HealthCare Recent Developments
Table 51. Millennium Pharmaceuticals Basic Information List
Table 52. Millennium Pharmaceuticals Description and Business Overview
Table 53. Millennium Pharmaceuticals Antibody Drug Conjugate (ADC) Drug Products, Services and Solutions
Table 54. Revenue (US$ Million) in Antibody Drug Conjugate (ADC) Drug Business of Millennium Pharmaceuticals (2019-2024)
Table 55. Millennium Pharmaceuticals Recent Developments
Table 56. Pfizer Basic Information List
Table 57. Pfizer Description and Business Overview
Table 58. Pfizer Antibody Drug Conjugate (ADC) Drug Products, Services and Solutions
Table 59. Revenue (US$ Million) in Antibody Drug Conjugate (ADC) Drug Business of Pfizer (2019-2024)
Table 60. Pfizer Recent Developments
Table 61. Concortis Bio therapeutics Basic Information List
Table 62. Concortis Bio therapeutics Description and Business Overview
Table 63. Concortis Bio therapeutics Antibody Drug Conjugate (ADC) Drug Products, Services and Solutions
Table 64. Revenue (US$ Million) in Antibody Drug Conjugate (ADC) Drug Business of Concortis Bio therapeutics (2019-2024)
Table 65. Concortis Bio therapeutics Recent Developments
Table 66. Roche Holding AG Basic Information List
Table 67. Roche Holding AG Description and Business Overview
Table 68. Roche Holding AG Antibody Drug Conjugate (ADC) Drug Products, Services and Solutions
Table 69. Revenue (US$ Million) in Antibody Drug Conjugate (ADC) Drug Business of Roche Holding AG (2019-2024)
Table 70. Roche Holding AG Recent Developments
Table 71. Seattle Genetics Basic Information List
Table 72. Seattle Genetics Description and Business Overview
Table 73. Seattle Genetics Antibody Drug Conjugate (ADC) Drug Products, Services and Solutions
Table 74. Revenue (US$ Million) in Antibody Drug Conjugate (ADC) Drug Business of Seattle Genetics (2019-2024)
Table 75. Seattle Genetics Recent Developments
Table 76. Heidelberg Pharma Basic Information List
Table 77. Heidelberg Pharma Description and Business Overview
Table 78. Heidelberg Pharma Antibody Drug Conjugate (ADC) Drug Products, Services and Solutions
Table 79. Revenue (US$ Million) in Antibody Drug Conjugate (ADC) Drug Business of Heidelberg Pharma (2019-2024)
Table 80. Heidelberg Pharma Recent Developments
Table 81. Mersana Therapeutics Basic Information List
Table 82. Mersana Therapeutics Description and Business Overview
Table 83. Mersana Therapeutics Antibody Drug Conjugate (ADC) Drug Products, Services and Solutions
Table 84. Revenue (US$ Million) in Antibody Drug Conjugate (ADC) Drug Business of Mersana Therapeutics (2019-2024)
Table 85. Mersana Therapeutics Recent Developments
Table 86. Astellas Pharma/Agensys Basic Information List
Table 87. Astellas Pharma/Agensys Description and Business Overview
Table 88. Astellas Pharma/Agensys Antibody Drug Conjugate (ADC) Drug Products, Services and Solutions
Table 89. Revenue (US$ Million) in Antibody Drug Conjugate (ADC) Drug Business of Astellas Pharma/Agensys (2019-2024)
Table 90. Astellas Pharma/Agensys Recent Developments
Table 91. AbbVie Inc Basic Information List
Table 92. AbbVie Inc Description and Business Overview
Table 93. AbbVie Inc Antibody Drug Conjugate (ADC) Drug Products, Services and Solutions
Table 94. Revenue (US$ Million) in Antibody Drug Conjugate (ADC) Drug Business of AbbVie Inc (2019-2024)
Table 95. AbbVie Inc Recent Developments
Table 96. Celldex Therapeutics Basic Information List
Table 97. Celldex Therapeutics Description and Business Overview
Table 98. Celldex Therapeutics Antibody Drug Conjugate (ADC) Drug Products, Services and Solutions
Table 99. Revenue (US$ Million) in Antibody Drug Conjugate (ADC) Drug Business of Celldex Therapeutics (2019-2024)
Table 100. Celldex Therapeutics Recent Developments
Table 101. Immunomedics Basic Information List
Table 102. Immunomedics Description and Business Overview
Table 103. Immunomedics Antibody Drug Conjugate (ADC) Drug Products, Services and Solutions
Table 104. Revenue (US$ Million) in Antibody Drug Conjugate (ADC) Drug Business of Immunomedics (2019-2024)
Table 105. Immunomedics Recent Developments
Table 106. Agensys Basic Information List
Table 107. Agensys Description and Business Overview
Table 108. Agensys Antibody Drug Conjugate (ADC) Drug Products, Services and Solutions
Table 109. Revenue (US$ Million) in Antibody Drug Conjugate (ADC) Drug Business of Agensys (2019-2024)
Table 110. Agensys Recent Developments
Table 111. Genentech Basic Information List
Table 112. Genentech Description and Business Overview
Table 113. Genentech Antibody Drug Conjugate (ADC) Drug Products, Services and Solutions
Table 114. Revenue (US$ Million) in Antibody Drug Conjugate (ADC) Drug Business of Genentech (2019-2024)
Table 115. Genentech Recent Developments
Table 116. ImmunoGen Basic Information List
Table 117. ImmunoGen Description and Business Overview
Table 118. ImmunoGen Antibody Drug Conjugate (ADC) Drug Products, Services and Solutions
Table 119. Revenue (US$ Million) in Antibody Drug Conjugate (ADC) Drug Business of ImmunoGen (2019-2024)
Table 120. ImmunoGen Recent Developments
Table 121. Sanofi Basic Information List
Table 122. Sanofi Description and Business Overview
Table 123. Sanofi Antibody Drug Conjugate (ADC) Drug Products, Services and Solutions
Table 124. Revenue (US$ Million) in Antibody Drug Conjugate (ADC) Drug Business of Sanofi (2019-2024)
Table 125. Sanofi Recent Developments
Table 126. Genmab Basic Information List
Table 127. Genmab Description and Business Overview
Table 128. Genmab Antibody Drug Conjugate (ADC) Drug Products, Services and Solutions
Table 129. Revenue (US$ Million) in Antibody Drug Conjugate (ADC) Drug Business of Genmab (2019-2024)
Table 130. Genmab Recent Developments
Table 131. Amgen Basic Information List
Table 132. Amgen Description and Business Overview
Table 133. Amgen Antibody Drug Conjugate (ADC) Drug Products, Services and Solutions
Table 134. Revenue (US$ Million) in Antibody Drug Conjugate (ADC) Drug Business of Amgen (2019-2024)
Table 135. Amgen Recent Developments
Table 136. Novartis Basic Information List
Table 137. Novartis Description and Business Overview
Table 138. Novartis Antibody Drug Conjugate (ADC) Drug Products, Services and Solutions
Table 139. Revenue (US$ Million) in Antibody Drug Conjugate (ADC) Drug Business of Novartis (2019-2024)
Table 140. Novartis Recent Developments
Table 141. Eli Lilly Basic Information List
Table 142. Eli Lilly Description and Business Overview
Table 143. Eli Lilly Antibody Drug Conjugate (ADC) Drug Products, Services and Solutions
Table 144. Revenue (US$ Million) in Antibody Drug Conjugate (ADC) Drug Business of Eli Lilly (2019-2024)
Table 145. Eli Lilly Recent Developments
Table 146. Key Raw Materials Lists
Table 147. Raw Materials Key Suppliers Lists
Table 148. Antibody Drug Conjugate (ADC) Drug Downstream Customers
Table 149. Antibody Drug Conjugate (ADC) Drug Distributors List
Table 150. Research Programs/Design for This Report
Table 151. Key Data Information from Secondary Sources
Table 152. Key Data Information from Primary Sources
Table 153. Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Antibody Drug Conjugate (ADC) Drug Product Picture
Figure 2. Global Antibody Drug Conjugate (ADC) Drug Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Antibody Drug Conjugate (ADC) Drug Sales Value (2019-2030) & (US$ Million)
Figure 4. Antibody Drug Conjugate (ADC) Drug Report Years Considered
Figure 5. Global Antibody Drug Conjugate (ADC) Drug Players Revenue Ranking (2023) & (US$ Million)
Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Antibody Drug Conjugate (ADC) Drug Revenue in 2023
Figure 7. Antibody Drug Conjugate (ADC) Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8. Mmunomedics Technology Picture
Figure 9. Immunogen Technology Picture
Figure 10. Seattle Genetics Technology Picture
Figure 11. Others Picture
Figure 12. Global Antibody Drug Conjugate (ADC) Drug Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 13. Global Antibody Drug Conjugate (ADC) Drug Sales Value Market Share by Type, 2023 & 2030
Figure 14. Product Picture of Biotechnology Companies
Figure 15. Product Picture of Specialized Cancer Centers
Figure 16. Product Picture of Biopharmaceutical Companies
Figure 17. Product Picture of Academic Research Institutes
Figure 18. Product Picture of Hospitals
Figure 19. Product Picture of Others
Figure 20. Global Antibody Drug Conjugate (ADC) Drug Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 21. Global Antibody Drug Conjugate (ADC) Drug Sales Value Market Share by Application, 2023 & 2030
Figure 22. North America Antibody Drug Conjugate (ADC) Drug Sales Value (2019-2030) & (US$ Million)
Figure 23. North America Antibody Drug Conjugate (ADC) Drug Sales Value by Country (%), 2023 VS 2030
Figure 24. Europe Antibody Drug Conjugate (ADC) Drug Sales Value (2019-2030) & (US$ Million)
Figure 25. Europe Antibody Drug Conjugate (ADC) Drug Sales Value by Country (%), 2023 VS 2030
Figure 26. Asia Pacific Antibody Drug Conjugate (ADC) Drug Sales Value (2019-2030) & (US$ Million)
Figure 27. Asia Pacific Antibody Drug Conjugate (ADC) Drug Sales Value by Country (%), 2023 VS 2030
Figure 28. South America Antibody Drug Conjugate (ADC) Drug Sales Value (2019-2030) & (US$ Million)
Figure 29. South America Antibody Drug Conjugate (ADC) Drug Sales Value by Country (%), 2023 VS 2030
Figure 30. Middle East & Africa Antibody Drug Conjugate (ADC) Drug Sales Value (2019-2030) & (US$ Million)
Figure 31. Middle East & Africa Antibody Drug Conjugate (ADC) Drug Sales Value by Country (%), 2023 VS 2030
Figure 32. Key Countries/Regions Antibody Drug Conjugate (ADC) Drug Sales Value (%), (2019-2030)
Figure 33. United States Antibody Drug Conjugate (ADC) Drug Sales Value, (2019-2030) & (US$ Million)
Figure 34. United States Antibody Drug Conjugate (ADC) Drug Sales Value by Type (%), 2023 VS 2030
Figure 35. United States Antibody Drug Conjugate (ADC) Drug Sales Value by Application (%), 2023 VS 2030
Figure 36. Europe Antibody Drug Conjugate (ADC) Drug Sales Value, (2019-2030) & (US$ Million)
Figure 37. Europe Antibody Drug Conjugate (ADC) Drug Sales Value by Type (%), 2023 VS 2030
Figure 38. Europe Antibody Drug Conjugate (ADC) Drug Sales Value by Application (%), 2023 VS 2030
Figure 39. China Antibody Drug Conjugate (ADC) Drug Sales Value, (2019-2030) & (US$ Million)
Figure 40. China Antibody Drug Conjugate (ADC) Drug Sales Value by Type (%), 2023 VS 2030
Figure 41. China Antibody Drug Conjugate (ADC) Drug Sales Value by Application (%), 2023 VS 2030
Figure 42. Japan Antibody Drug Conjugate (ADC) Drug Sales Value, (2019-2030) & (US$ Million)
Figure 43. Japan Antibody Drug Conjugate (ADC) Drug Sales Value by Type (%), 2023 VS 2030
Figure 44. Japan Antibody Drug Conjugate (ADC) Drug Sales Value by Application (%), 2023 VS 2030
Figure 45. South Korea Antibody Drug Conjugate (ADC) Drug Sales Value, (2019-2030) & (US$ Million)
Figure 46. South Korea Antibody Drug Conjugate (ADC) Drug Sales Value by Type (%), 2023 VS 2030
Figure 47. South Korea Antibody Drug Conjugate (ADC) Drug Sales Value by Application (%), 2023 VS 2030
Figure 48. Southeast Asia Antibody Drug Conjugate (ADC) Drug Sales Value, (2019-2030) & (US$ Million)
Figure 49. Southeast Asia Antibody Drug Conjugate (ADC) Drug Sales Value by Type (%), 2023 VS 2030
Figure 50. Southeast Asia Antibody Drug Conjugate (ADC) Drug Sales Value by Application (%), 2023 VS 2030
Figure 51. India Antibody Drug Conjugate (ADC) Drug Sales Value, (2019-2030) & (US$ Million)
Figure 52. India Antibody Drug Conjugate (ADC) Drug Sales Value by Type (%), 2023 VS 2030
Figure 53. India Antibody Drug Conjugate (ADC) Drug Sales Value by Application (%), 2023 VS 2030
Figure 54. Antibody Drug Conjugate (ADC) Drug Industrial Chain
Figure 55. Antibody Drug Conjugate (ADC) Drug Manufacturing Cost Structure
Figure 56. Channels of Distribution (Direct Sales, and Distribution)
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
